Literature DB >> 27909224

Sarcomeric protein modification during adrenergic stress enhances cross-bridge kinetics and cardiac output.

Kenneth S Gresham1, Ranganath Mamidi1, Jiayang Li1, Hyerin Kwak1, Julian E Stelzer2.   

Abstract

Molecular adaptations to chronic neurohormonal stress, including sarcomeric protein cleavage and phosphorylation, provide a mechanism to increase ventricular contractility and enhance cardiac output, yet the link between sarcomeric protein modifications and changes in myocardial function remains unclear. To examine the effects of neurohormonal stress on posttranslational modifications of sarcomeric proteins, mice were administered combined α- and β-adrenergic receptor agonists (isoproterenol and phenylephrine, IPE) for 14 days using implantable osmotic pumps. In addition to significant cardiac hypertrophy and increased maximal ventricular pressure, IPE treatment accelerated pressure development and relaxation (74% increase in dP/dtmax and 14% decrease in τ), resulting in a 52% increase in cardiac output compared with saline (SAL)-treated mice. Accelerated pressure development was maintained when accounting for changes in heart rate and preload, suggesting that myocardial adaptations contribute to enhanced ventricular contractility. Ventricular myocardium isolated from IPE-treated mice displayed a significant reduction in troponin I (TnI) and myosin-binding protein C (MyBP-C) expression and a concomitant increase in the phosphorylation levels of the remaining TnI and MyBP-C protein compared with myocardium isolated from saline-treated control mice. Skinned myocardium isolated from IPE-treated mice displayed a significant acceleration in the rate of cross-bridge (XB) detachment (46% increase) and an enhanced magnitude of XB recruitment (43% increase) at submaximal Ca2+ activation compared with SAL-treated mice but unaltered myofilament Ca2+ sensitivity of force generation. These findings demonstrate that sarcomeric protein modifications during neurohormonal stress are molecular adaptations that enhance in vivo ventricular contractility through accelerated XB kinetics to increase cardiac output.NEW & NOTEWORTHY Posttranslational modifications to sarcomeric regulatory proteins provide a mechanism to modulate cardiac function in response to stress. In this study, we demonstrate that neurohormonal stress produces modifications to myosin-binding protein C and troponin I, including a reduction in protein expression within the sarcomere and increased phosphorylation of the remaining protein, which serve to enhance cross-bridge kinetics and increase cardiac output. These findings highlight the importance of sarcomeric regulatory protein modifications in modulating ventricular function during cardiac stress.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  cardiac contractility; myosin-binding protein C; posttranslational modifications; troponin I

Mesh:

Substances:

Year:  2016        PMID: 27909224      PMCID: PMC5401951          DOI: 10.1152/japplphysiol.00306.2016

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  59 in total

1.  SLControl: PC-based data acquisition and analysis for muscle mechanics.

Authors:  Kenneth S Campbell; Richard L Moss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-07       Impact factor: 4.733

2.  Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts.

Authors:  M V Westfall; R J Solaro
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

Review 3.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

4.  Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart.

Authors:  R J Solaro; A J Moir; S V Perry
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

5.  Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.

Authors:  Xiao-Jun Du; Lin Fang; Xiao-Ming Gao; Helen Kiriazis; Xinheng Feng; Elodie Hotchkin; Angela M Finch; Hervé Chaulet; Robert M Graham
Journal:  J Mol Cell Cardiol       Date:  2004-11       Impact factor: 5.000

6.  NH2-terminal truncations of cardiac troponin I and cardiac troponin T produce distinct effects on contractility and calcium homeostasis in adult cardiomyocytes.

Authors:  Hongguang Wei; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2014-12-17       Impact factor: 4.249

7.  Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites.

Authors:  Eiki Takimoto; David G Soergel; Paul M L Janssen; Linda B Stull; David A Kass; Anne M Murphy
Journal:  Circ Res       Date:  2004-01-15       Impact factor: 17.367

8.  Effects of pseudo-phosphorylated rat cardiac troponin T are differently modulated by α- and β-myosin heavy chain isoforms.

Authors:  John Jeshurun Michael; Sampath K Gollapudi; Murali Chandra
Journal:  Basic Res Cardiol       Date:  2014-10-10       Impact factor: 17.165

9.  Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.

Authors:  Emmanuel Letavernier; Joëlle Perez; Agnès Bellocq; Laurent Mesnard; Alexandre de Castro Keller; Jean-Philippe Haymann; Laurent Baud
Journal:  Circ Res       Date:  2008-02-07       Impact factor: 17.367

10.  Length-dependent changes in contractile dynamics are blunted due to cardiac myosin binding protein-C ablation.

Authors:  Ranganath Mamidi; Kenneth S Gresham; Julian E Stelzer
Journal:  Front Physiol       Date:  2014-12-02       Impact factor: 4.566

View more
  8 in total

1.  Myocardial-restricted ablation of the GTPase RAD results in a pro-adaptive heart response in mice.

Authors:  Brooke M Ahern; Bryana M Levitan; Sudhakar Veeranki; Mihir Shah; Nemat Ali; Andrea Sebastian; Wen Su; Ming C Gong; Jiayang Li; Julian E Stelzer; Douglas A Andres; Jonathan Satin
Journal:  J Biol Chem       Date:  2019-05-30       Impact factor: 5.157

2.  Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium.

Authors:  Ranganath Mamidi; Jiayang Li; Kenneth S Gresham; Sujeet Verma; Chang Yoon Doh; Amy Li; Sean Lal; Cristobal G Dos Remedios; Julian E Stelzer
Journal:  Circ Heart Fail       Date:  2017-10       Impact factor: 8.790

3.  Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy.

Authors:  Jiayang Li; Kenneth S Gresham; Ranganath Mamidi; Chang Yoon Doh; Xiaoping Wan; Isabelle Deschenes; Julian E Stelzer
Journal:  Int J Cardiol       Date:  2018-09-21       Impact factor: 4.164

4.  Recovery of left ventricular function following in vivo reexpression of cardiac myosin binding protein C.

Authors:  Jasmine Giles; Jitandrakumar R Patel; Adam Miller; Elizabeth Iverson; Daniel Fitzsimons; Richard L Moss
Journal:  J Gen Physiol       Date:  2018-12-20       Impact factor: 4.086

5.  cMyBP-C phosphorylation modulates the time-dependent slowing of unloaded shortening in murine skinned myocardium.

Authors:  Jasmine Giles; Daniel P Fitzsimons; Jitandrakumar R Patel; Chloe Knudtsen; Zander Neuville; Richard L Moss
Journal:  J Gen Physiol       Date:  2021-03-01       Impact factor: 4.086

6.  Chronic isoprenaline/phenylephrine vs. exclusive isoprenaline stimulation in mice: critical contribution of alpha1-adrenoceptors to early cardiac stress responses.

Authors:  Matthias Dewenter; Jianyuan Pan; Laura Knödler; Niklas Tzschöckel; Julian Henrich; Julio Cordero; Gergana Dobreva; Susanne Lutz; Johannes Backs; Thomas Wieland; Christiane Vettel
Journal:  Basic Res Cardiol       Date:  2022-03-14       Impact factor: 12.416

7.  Impact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility.

Authors:  Ranganath Mamidi; Jiayang Li; Chang Yoon Doh; Sujeet Verma; Julian E Stelzer
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

8.  AAV9 gene transfer of cMyBPC N-terminal domains ameliorates cardiomyopathy in cMyBPC-deficient mice.

Authors:  Jiayang Li; Ranganath Mamidi; Chang Yoon Doh; Joshua B Holmes; Nikhil Bharambe; Rajesh Ramachandran; Julian E Stelzer
Journal:  JCI Insight       Date:  2020-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.